# Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it

> **NCT03953183** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 60 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **OTHER:** P3P-1mg
- **OTHER:** P3P-2mg

## Key facts

- **NCT ID:** NCT03953183
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-23
- **Primary completion:** 2019-08-14
- **Final completion:** 2019-10-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953183, "Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03953183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*